Mbiotech to distribute Gene Bridges Recombineering Technology in Korea
Gene Bridges GmbH announced that Mbiotech will distribute Gene Bridges' patented Red/ET recombination technology in Korea. Mbiotech was selected due to its expertise producing and marketing a wide range of molecular biology reagents.
Under the terms of the agreement, Mbiotech will be the exclusive source of recombineering kits and reagents for the Korean the biotech community.
Mbiotech is a privately owned manufacturing and distribution company located in Seoul, Korea. The Company specialises in manufacturing a range of products including protein markers, DNA markers, Taq DNA polymerase and Nucleic Acid purification kits. Mbiotech distributes their products worldwide, using a variety of different companies and channels.
Other news from the department business & finance
These products might interest you

Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation

DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference

DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection

Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines

CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy

Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
BASF divests Omega-3 production plant
AMSBIO and Chondrex Cooperate On Arthritis & Inflammation Research
Canadian authorities grant product approval for Intercell's Vaccine to prevent Japanese Encephalitis

Atomic insights into plant growth - Researchers from Tübingen resolve how a plant steroid hormone makes plants grow
Breakthroughs in Chikungunya Research Led by A*STAR Scientists Spell New Hope for Better Treatment and Protection
Euphorbia_poisonii

Toxic agents behind Parkinson's disease seen at work for the first time - First look at how toxic protein clusters disrupt the membranes of healthy brain cells.

Nanoscale Velcro used for Molecule Transport
